Alessandro Gozzetti

Papers authored by Alessandro Gozzetti

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2021 A. Visentin, S. Pravato, F. R. Mauro, D. Pietrasanta, A. Fresa, C. Vitale, S. Ciolli, R. Cassin, F. Cibien, P. Sportoletti, M. Gentile, G. M. Rigolin, F. M. Quaglia, R. Murru, A. Gozzetti

and 13 other authors

Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia Without Tp53 Disruptions. A Campus CLL Study

Upload

F. Morelli, F. Ghio, F. Simonetti, A. Cuccaro, L. Mannelli, A. Gozzetti

, S. Santini, F. Mavilla, E. Capochiani, A. M. Vannucchi, A. Sanna

Frontline Therapy With Obinotuzumab Chlorambucil in CLL Patients: A Real-Life Experience

Upload

Francesca Bacchiarri, Vincenzo Sammartano, Adele Santoni, Donatella Raspadori, Elisabetta Zappone, Marzia Defina, Sara Ciofini, Anna Sicuranza, Monica Bocchia, Alessandro Gozzetti

First reported case of secondary mixed phenotype acute leukemia after multiple myeloma

Upload

This paper is made freely available by the publisher.

Gian Matteo Rigolin, Rigolin Gm, Francesco Cavazzini, Alfonso Piciocchi

, Valentina Arena, Andrea Visentin, Gianluigi Reda, Marzia Varettoni, Rossella Paolini, Giulia Zamprogna, Paolo Sportoletti, Daniela Pietrasanta, Francesca Cibien, Anna Lia Molinari, Francesca M. Quaglia and 35 other authors

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

Download from onlinelibrary.wiley.com

S. Oliva, E. Genuardi, D. Rota-Scalabrini, E. Zamagni, D. Auclair, A. P. Jacob, R. Zambello, A. Spadano, N. Giuliani, A. Cuoghi, L. De Rosa, L. Visca, A. Gozzetti

, G. Pietrantuono, F. Patriarca and 8 other authors

Minimal Residual Disease (Mrd) by Multiparameter Flow Cytometry (Mfc) and Next-Generation Sequencing (Ngs) in Newly Diagnosed Transplant-Eligible Multiple Myeloma (Ndmm): Results From the Forte Trial

Upload

Roberto Mina, Elena Zamagni, Delia Rota-Scalabrini, Paolo Corradini, Mariella Grasso, Stelvio Ballanti, Nicola Giuliani, Luca De Rosa, Claudia Cellini, Iolanda Donatella Vincelli, Cristina Velluti, Andrea Capra, Anna Maria Cafro, Alessandro Gozzetti

, Massimo Gentile and 7 other authors

Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study

Upload

F. Nardi, A. Di Rita, L. Pezzella, S. Ciofini, A. Gozzetti

, M. Bocchia, A. Kabanova

Gene editing and expression in hard-to-manipulate primary tumour cells by CRISPR/Cas9 and mRNA technology

Upload

2020 Ajai Chari, Mehmet Kemal Samur, Samur Mk, Joaquin Martinez-Lopez

, Gordon Cook

, Noa Biran

, Kwee Yong

, Vania Hungria

, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva

, Rimke Oostvogels

, Alessandro Gozzetti

, Cara Rosenbaum and 11 other authors

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Download from ashpublications.org

Alessandro Gozzetti

, Francesca Bacchiarri, Vincenzo Sammartano, Marzia Defina, Anna Sicuranza, Bianca Mecacci, Elisabetta Zappone, Emanuele Cencini, Alberto Fabbri, Donatella Raspadori, Monica Bocchia

Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients

Download from doi.org

Alessandro Gozzetti

, Vincenzo Sammartano, Francesca Bacchiarri, Donatella Raspadori, Monica Bocchia

A BRAF-Negative Classic Hairy Cell Leukemia Patient with LongLasting Complete Remission after Rituximab and Pentostatin

Download from doi.org

Gian Matteo Rigolin, Annamaria Frustaci, Alfonso Piciocchi, Andrea Visentin, Orsola Vitagliano, Marta Coscia, Lucia Farina, Gianluca Gaidano, Roberta Murru, Marzia Varettoni, Luca Arcaini, Francesca Cibien, Rossella Paolini, Paolo Sportoletti, Daniela Pietrasanta and 31 other authors

Efficacy of Idelalisib and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Treated Outside of Clinical Trial. a Report of the Gimema Group

Download from ashpublications.org

Distributing this paper is prohibited by the publisher

Alessandro Gozzetti

, Donatella Raspadori, Paola Pacelli, Elisabetta Antonioli, Elena Bestoso, Sara Ciofini, Francesca Bacchiarri, Gabriele Buda, Dania Tocci, Cristiana Cafarelli, Anna Marina Liberati, Piero Galieni, Giulia Lucco Navei, Ubaldo Occhini, Anna Sicuranza and 5 other authors

Minimal Residual Disease (MRD) at 10-6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication)

Upload

Andrea Visentin, Francesca Romana Mauro, Daniela Pietrasanta, Alberto Fresa, Candida Vitale, Stefania Ciolli, Ramona Cassin, Francesca Cibien, Paolo Sportoletti, Massimo Gentile, Gian Matteo Rigolin, Francesca M. Quaglia, Roberta Murru, Alessandro Gozzetti

, Stefano Molica and 10 other authors

Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus

Download from ashpublications.org

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti

, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas and 7 other authors

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Upload

Alessandro Gozzetti

, Alfonso Cerase

, Monica Bocchia

Daratumumab efficacy in extramedullary orbital myeloma

Download from onlinelibrary.wiley.com

María-Victoria Mateos

, Shaji Kumar

, Meletios A. Dimopoulos

, Verónica González-Calle, Efstathios Kastritis, Roman Hajek, Carlos Fernández De Larrea, Gareth J. Morgan, Giampaolo Merlini

, Hartmut Goldschmidt

, Catarina Geraldes, Alessandro Gozzetti

, Charalampia Kyriakou, Laurent Garderet, Markus Hansson

and 14 other authors

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

Download from www.nature.com

Alessandro Gozzetti

, Donatella Raspadori, Francesca Bacchiarri, Anna Sicuranza, Paola Pacelli, Ilaria Ferrigno, Dania Tocci, Monica Bocchia

Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice

Download from doi.org

Alessandro Gozzetti

, Enrico Capochiani, Monica Bocchia

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

Download from www.nature.com

Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, Paolo Roncucci, Annarosa Cuccaro

, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente and 3 other authors

Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

Download from doi.org

Elisabetta Zappone, Emanuele Cencini

, Marzia Defina, Anna Sicuranza, Alessandro Gozzetti

, Sara Ciofini, Donatella Raspadori, Bianca Mecacci, Monica Bocchia

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia

Download from api.wiley.com